Skip to main content
TipRanks
Go Ultimate75% OFF

Revive Therapeutics (RVVTF) Income Statement

58 Followers

Revive Therapeutics Income Statement

Last quarter (Q4 2026), Revive Therapeutics's total revenue was C$0.00. In Q4, Revive Therapeutics's net income was C$3.33K. See Revive Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 26Sep 25Sep 24Sep 23Sep 22
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
C$ -189.00C$ -248.00C$ -328.00C$ -434.00C$ -578.00
C$ 1.05MC$ 1.65MC$ 3.29MC$ 5.52MC$ 17.83M
Depreciation and AmortizationC$ 189.00C$ 248.00C$ 328.00C$ 434.00C$ 578.00
C$ -1.05MC$ -11.01MC$ -5.60MC$ -5.52MC$ -17.74M
C$ -1.05MC$ -1.65MC$ -3.29MC$ -5.52MC$ -17.83M
C$ 30.84KC$ -9.36MC$ -2.33MC$ -796.15KC$ 26.10K
C$ -1.02MC$ -11.01MC$ -5.62MC$ -6.32MC$ -17.81M
C$ -1.02MC$ -11.01MC$ -5.62MC$ -6.32MC$ -17.83M
Per Share Metrics
Basic EPSC$ -0.00C$ -0.03C$ -0.01C$ -0.02C$ -0.06
Diluted EPSC$ -0.00C$ -0.03C$ -0.01C$ -0.02C$ -0.06
Weighted Average Shares Outstanding434.07M419.71M380.48M339.37M319.76M
Weighted Average Shares Outstanding (Diluted)434.07M419.71M380.48M339.37M319.76M

Currency in CAD

Revive Therapeutics Earnings and Revenue History

-24M-16M-8M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720192020202120222023202420252026RevenueEarningsProfit Margin